Autosomal dominant nonsyndromic hearing loss: genes and variants
Explore variant evidence for Autosomal dominant nonsyndromic hearing loss across 12 analyzed proteins (KCNQ4, TECTA, MYO7A, SIX1, GJB2 and 7 more). Linked ClinVar records include 72 pathogenic or likely pathogenic variants, 312 variants of uncertain significance and 93 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Autosomal dominant nonsyndromic hearing loss
KCNQ4: Potassium voltage-gated channel subfamily KQT member 4
Its potassium conductance is crucial for electrical homeostasis in cochlear outer hair cells and auditory pathways. Dominant pathogenic variants are a well-established cause of progressive nonsyndromic sensorineural hearing loss, classically DFNA2.
19 ClinVar pathogenic / likely pathogenic and 27 uncertain variants in KCNQ4 have source records linked to Autosomal dominant nonsyndromic hearing loss. Association strength is not clinical gene validity.
TECTA: Alpha-tectorin
Its extracellular matrix organizes the tectorial membrane that mechanically couples sound-induced motion to cochlear hair cells. Dominant or recessive pathogenic variants cause nonsyndromic hearing loss, with characteristic frequency patterns depending on the affected region.
15 ClinVar pathogenic / likely pathogenic and 91 uncertain variants in TECTA have source records linked to Autosomal dominant nonsyndromic hearing loss. Association strength is not clinical gene validity.
MYO7A: Unconventional myosin-VIIa
Its actin-based motor supports stereocilia organization in inner-ear hair cells and transport processes in retinal cells. Biallelic pathogenic variants cause Usher syndrome type 1B, while other alleles can cause nonsyndromic hearing loss.
13 ClinVar pathogenic / likely pathogenic and 128 uncertain variants in MYO7A have source records linked to Autosomal dominant nonsyndromic hearing loss. Association strength is not clinical gene validity.
SIX1: Homeobox protein SIX1
It regulates developmental programs in the ear, kidney, craniofacial structures, and skeletal muscle together with EYA-family cofactors. Heterozygous pathogenic variants cause branchio-otic or branchio-oto-renal syndrome with hearing loss and variable branchial or renal abnormalities.
8 ClinVar pathogenic / likely pathogenic and 61 uncertain variants in SIX1 have source records linked to Autosomal dominant nonsyndromic hearing loss. Association strength is not clinical gene validity.
GJB2: Gap junction beta-2 protein
Its connexin 26 channels support potassium and metabolite recycling within the cochlea and communication across epithelial gap junctions. Biallelic pathogenic variants are among the most common causes of congenital nonsyndromic hearing loss, while dominant variants can cause syndromic deafness with skin disease.
8 ClinVar pathogenic / likely pathogenic and 13 uncertain variants in GJB2 have source records linked to Autosomal dominant nonsyndromic hearing loss. Association strength is not clinical gene validity.
TMC1: Transmembrane channel-like protein 1
A pore-forming component of the mechanotransduction channel at the tips of cochlear hair-cell stereocilia. Variants can cause inherited hearing loss.
4 ClinVar pathogenic / likely pathogenic and 31 uncertain variants in TMC1 have source records linked to Autosomal dominant nonsyndromic hearing loss. Association strength is not clinical gene validity.
GJB6: Gap junction beta-6 protein
It forms connexin 30 gap junctions in the cochlea, skin, and other epithelia and contributes to intercellular ion and metabolite exchange. Deletions or pathogenic variants can cause nonsyndromic hearing loss or ectodermal dysplasia syndromes.
3 ClinVar pathogenic / likely pathogenic and 41 uncertain variants in GJB6 have source records linked to Autosomal dominant nonsyndromic hearing loss. Association strength is not clinical gene validity.
MYO6: Unconventional myosin-VI
A reverse-direction actin motor involved in intracellular transport and organization of hair-cell stereocilia. Variants can cause inherited hearing loss.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in MYO6 have source records linked to Autosomal dominant nonsyndromic hearing loss. Association strength is not clinical gene validity.
POLE: DNA polymerase epsilon catalytic subunit A
It performs leading-strand DNA synthesis and proofreads newly incorporated bases during replication. Germline exonuclease-domain variants cause polymerase-proofreading-associated polyposis, while somatic proofreading defects create ultramutated tumors with distinctive mutation signatures.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in POLE have source records linked to Autosomal dominant nonsyndromic hearing loss. Association strength is not clinical gene validity.
COL11A1: Collagen alpha-1(XI) chain
A chain of type XI collagen, an extracellular-matrix protein found in cartilage and the eye. Variants can cause Stickler or Marshall syndrome.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in COL11A1 have source records linked to Autosomal dominant nonsyndromic hearing loss. Association strength is not clinical gene validity.
NLRP3: NACHT, LRR and PYD domains-containing protein 3
It assembles a widely used inflammasome in response to diverse danger signals, driving caspase-1 activation and release of IL-1beta and IL-18. Gain-of-function variants cause cryopyrin-associated periodic syndromes, while excessive activation contributes to common inflammatory diseases.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NLRP3 have source records linked to Autosomal dominant nonsyndromic hearing loss. Association strength is not clinical gene validity.
MCM2: DNA replication licensing factor MCM2
It is part of the MCM2-7 helicase that unwinds DNA at replication forks and licenses origins before S phase. Excess or dysregulated expression is common in proliferative cancers and is widely used as a marker of active DNA replication.
0 ClinVar pathogenic / likely pathogenic and 9 uncertain variants in MCM2 have source records linked to Autosomal dominant nonsyndromic hearing loss. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): ABCC1 and USH2A.
Where Autosomal dominant nonsyndromic hearing loss variants cluster
- KCNQ4 Segment H5 (positions 271–292): 9 of 19 ClinVar pathogenic / likely pathogenic variants, 15.0× more than its size predicts (a length-based count, not a validated hotspot).
- TECTA ZP (positions 1805–2059): 10 of 15 ClinVar pathogenic / likely pathogenic variants, 5.6× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Autosomal dominant nonsyndromic hearing loss
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MYO7A E450V | 450 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| GJB2 T86R | 86 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| KCNQ4 L281S | 281 | Segment H5 | Pathogenic / likely pathogenic (★★) |
| MYO7A G1497R | 1497 | FERM 1 | Pathogenic / likely pathogenic (★★) |
| TECTA R2021H | 2021 | ZP | Pathogenic / likely pathogenic (★★) |
| GJB2 R32L | 32 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 I82M | 82 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 E147K | 147 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 R184W | 184 | Extracellular | Pathogenic / likely pathogenic (★★) |
| MYO7A E450Q | 450 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| TECTA R2021C | 2021 | ZP | Pathogenic / likely pathogenic (★★) |
| KCNQ4 P291L | 291 | Segment H5 | Pathogenic / likely pathogenic (★★) |
| MYO7A R241G | 241 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A A397T | 397 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R657W | 657 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R668H | 668 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R853C | 853 | IQ 5 | Pathogenic / likely pathogenic (★★) |
| MYO7A G2137R | 2137 | FERM 2 | Pathogenic / likely pathogenic (★★) |
| SIX1 R110W | 110 | Pathogenic / likely pathogenic (★★) | |
| MYO7A M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| GJB6 A88V | 88 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| MYO7A D2010N | 2010 | FERM 2 | Pathogenic / likely pathogenic (★★) |
| MYO7A G2163S | 2163 | FERM 2 | Pathogenic / likely pathogenic (★★) |
| SIX1 E125K | 125 | Homeobox | Pathogenic / likely pathogenic (★★) |
| TECTA C1057S | 1057 | Pathogenic / likely pathogenic (★★) | |
| TMC1 I677T | 677 | Extracellular | Pathogenic / likely pathogenic (★★) |
| KCNQ4 L47P | 47 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| TMC1 I266T | 266 | Extracellular | Pathogenic / likely pathogenic (★★) |
| TMC1 D684H | 684 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GJB2 D179H | 179 | Extracellular | Pathogenic / likely pathogenic (★) |
| TECTA C1837Y | 1837 | ZP | Pathogenic / likely pathogenic (★) |
| GJB2 D179N | 179 | Extracellular | Pathogenic / likely pathogenic (★) |
| KCNQ4 G287S | 287 | Segment H5 | Pathogenic / likely pathogenic (★) |
| TECTA C1837R | 1837 | ZP | Pathogenic / likely pathogenic (★) |
| KCNQ4 W224R | 224 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| KCNQ4 G321S | 321 | Segment S6 | Pathogenic / likely pathogenic (★) |
| KCNQ4 W276R | 276 | Segment H5 | Pathogenic / likely pathogenic (★) |
| SIX1 Y129C | 129 | Homeobox | Pathogenic / likely pathogenic (★) |
| GJB6 G11R | 11 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| KCNQ4 H234L | 234 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| KCNQ4 F549L | 549 | Interaction with CALM | Pathogenic / likely pathogenic (★) |
| SIX1 R110L | 110 | Pathogenic / likely pathogenic (★) | |
| GJB2 P58S | 58 | Extracellular | Pathogenic / likely pathogenic (★) |
| KCNQ4 G245R | 245 | Segment S5 | Pathogenic / likely pathogenic (★) |
| MYO7A D511N | 511 | Myosin motor | Pathogenic / likely pathogenic (★) |
| POLE R37P | 37 | Pathogenic / likely pathogenic (★) | |
| TECTA T190P | 190 | NIDO | Pathogenic / likely pathogenic (★) |
| TECTA G434V | 434 | VWFD 1 | Pathogenic / likely pathogenic (★) |
| TECTA S1847P | 1847 | ZP | Pathogenic / likely pathogenic (★) |
| TECTA Y1870C | 1870 | ZP | Pathogenic / likely pathogenic (★) |
| TECTA R1890C | 1890 | ZP | Pathogenic / likely pathogenic (★) |
| SIX1 V106L | 106 | Pathogenic / likely pathogenic (★) | |
| SIX1 K114E | 114 | Pathogenic / likely pathogenic (★) | |
| SIX1 P118L | 118 | Pathogenic / likely pathogenic (★) | |
| KCNQ4 D266Y | 266 | Extracellular | Pathogenic / likely pathogenic (★) |
| KCNQ4 P291S | 291 | Segment H5 | Pathogenic / likely pathogenic |
| KCNQ4 G287R | 287 | Segment H5 | Pathogenic / likely pathogenic |
| TECTA C1837G | 1837 | ZP | Pathogenic / likely pathogenic |
| KCNQ4 V230E | 230 | Cytoplasmic | Pathogenic / likely pathogenic |
| KCNQ4 L274H | 274 | Segment H5 | Pathogenic / likely pathogenic |
Showing 60 of 72.
Which prediction tools work for Autosomal dominant nonsyndromic hearing loss
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 94 out of 100
- REVEL: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 84 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 84 out of 100
- ESM1b (LLR): 84 out of 100
- CADD: 83 out of 100
- MetaLR: 82 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 76 out of 100
- phyloP: 69 out of 100
- Pangolin: 54 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 52 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Rare genetic deafness also has ClinVar records linked to TECTA variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (3 pathogenic / likely pathogenic).
- Usher syndrome also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (80 pathogenic / likely pathogenic).
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (26 pathogenic / likely pathogenic).
- Rare genetic deafness also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (23 pathogenic / likely pathogenic).
- Hearing loss also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (4 pathogenic / likely pathogenic).
- Nonsyndromic genetic hearing loss also has ClinVar records linked to MYO7A variants; they fall partly in the same places as the Autosomal dominant nonsyndromic hearing loss variants (4 pathogenic / likely pathogenic).
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to GJB2 variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (38 pathogenic / likely pathogenic).
- Nonsyndromic genetic hearing loss also has ClinVar records linked to GJB2 variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (28 pathogenic / likely pathogenic).
- Rare genetic deafness also has ClinVar records linked to GJB2 variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (25 pathogenic / likely pathogenic).
- Mutilating keratoderma also has ClinVar records linked to GJB2 variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (15 pathogenic / likely pathogenic).
- Ichthyosis, hystrix-like, with hearing loss also has ClinVar records linked to GJB2 variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (13 pathogenic / likely pathogenic).
- Branchiootic syndrome also has ClinVar records linked to SIX1 variants; they fall partly in the same places as the Autosomal dominant nonsyndromic hearing loss variants (11 pathogenic / likely pathogenic).
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to TMC1 variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (15 pathogenic / likely pathogenic).
- Hearing loss also has ClinVar records linked to TMC1 variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (7 pathogenic / likely pathogenic).
- Nonsyndromic genetic hearing loss also has ClinVar records linked to TMC1 variants; they fall mostly in different places as the Autosomal dominant nonsyndromic hearing loss variants (4 pathogenic / likely pathogenic).
Diseases related to Autosomal dominant nonsyndromic hearing loss
- Hearing loss, also linked to COL11A1, GJB2, GJB6, MYO6 and 3 more
- Monogenic hearing loss, also linked to COL11A1, GJB2, KCNQ4, MYO6 and 3 more
- Rare genetic deafness, also linked to GJB2, KCNQ4, MYO6, MYO7A and 2 more
- Nonsyndromic genetic hearing loss, also linked to GJB2, KCNQ4, MYO6, MYO7A and 2 more
- Autosomal recessive nonsyndromic hearing loss, also linked to GJB2, GJB6, MYO7A, TECTA and 1 more
- Deafness, also linked to GJB2, MCM2, MYO7A, TECTA and 1 more
- Bilateral sensorineural hearing impairment, also linked to KCNQ4 and TMC1
- Ear malformation, also linked to MYO7A and TECTA
- Retinitis pigmentosa, also linked to MYO7A
- Noonan syndrome, also linked to GJB2
- Usher syndrome, also linked to MYO7A
- Ovarian cancer, also linked to POLE
Frequently asked questions
Which genes have records linked to Autosomal dominant nonsyndromic hearing loss?
This view contains 12 analyzed proteins: KCNQ4, TECTA, MYO7A, SIX1, GJB2 and 7 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 72 pathogenic or likely pathogenic variants, 312 variants of uncertain significance and 93 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 606 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center